Clinical Profile, Microbiological Spectrum, Antibiotic Sensitivity Pattern, and Treatment Outcomes of Infectious Keratitis in a Tertiary Care Hospital
Keywords:
Infectious keratitis, Microbial keratitis, Corneal ulcer, Antibiotic susceptibility, Ocular trauma, Microbiological spectrum, Treatment outcomesAbstract
Background: Infectious keratitis is a major ophthalmic emergency and an important cause of preventable visual impairment. Early identification of causative microorganisms and their antimicrobial susceptibility patterns is essential for effective treatment and prevention of corneal complications.
Aim: To evaluate the clinical profile, microbiological spectrum, antibiotic sensitivity pattern, and treatment outcomes of infectious keratitis in a tertiary care hospital.
Materials and Methods: This prospective observational study included 110 patients with clinically diagnosed infectious keratitis. Demographic characteristics, predisposing factors, clinical findings, and visual acuity were recorded. Corneal scrapings underwent microscopy, microbial culture, and antibiotic susceptibility testing. Treatment outcomes were assessed during a three-month follow-up period.
Results: Males constituted 61.8% of patients, and 59.1% belonged to rural areas. Ocular trauma was the predominant predisposing factor (40.9%). Culture positivity was observed in 70.9% of cases, comprising bacterial (52.7%), fungal (16.4%), and mixed infections (1.8%). Staphylococcus aureus (40.0%) and Fusarium species (45.0%) were the predominant bacterial and fungal isolates, respectively. Gram-positive isolates demonstrated maximum susceptibility to vancomycin (97.7%), while Gram-negative isolates showed highest susceptibility to amikacin (93.8%). Medical resolution was achieved in 83.6% of patients, although 66.4% developed residual corneal scarring. Therapeutic keratoplasty was required in 9.1% of cases.
Conclusion: Infectious keratitis predominantly affected individuals with occupational ocular trauma. Bacterial infections were more frequent than fungal infections. Early microbiological diagnosis, susceptibility-guided antimicrobial therapy, and timely intervention are essential for improving treatment outcomes and minimizing permanent visual impairment.
References
Cabrera-Aguas M, Khoo P, Watson SL. Infectious keratitis: a review. Clin Exp Ophthalmol. 2022;50(5):543-62.
Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (Lond). 2021;35(4):1084-101.
Parmar GS, Meena AK, Borde P, Prasad S. Microbial keratitis and antibiotic sensitivity patterns: a retrospective analysis at a tertiary center in Central India. Indian J Ophthalmol. 2023;71(6):2455-9.
Acharya M, Farooqui JH, Gaba T, Gandhi A, Mathur U. Delhi Infectious Keratitis Study: update on clinico-microbiological profile and outcomes of infectious keratitis. J Curr Ophthalmol. 2020;32(3):249-55.
Kusumesh R, Ambastha A, Arya LK, Kumari A, Kumari N, Sinha BP, et al. Epidemiological and microbiological profiles of microbial keratitis in a tertiary eye center in Eastern India (Bihar). Indian J Ophthalmol. 2023;71(11):3506-12.
Ahmed NH, Mishra D, Rathod P, Satpathy G, Titiyal JS, Tandon R, et al. Spectrum of bacterial keratitis in North India: a retrospective analysis of six years at a tertiary care eye center. Indian J Ophthalmol. 2022;70(6):1982-9.
Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131(4):422-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr. Bhadra Priya et al

This work is licensed under a Creative Commons Attribution 4.0 International License.



